NASDAQ:AXLA

Axcella Health Stock Forecast, Price & News

$5.48

-0.30 (-5.19 %)

(As of 01/27/2021 12:00 AM ET)

Add

Compare

Today's Range

$5.40

Now: $5.48▼

$5.85

50-Day Range

$5.04

MA: $5.52▼

$5.99

52-Week Range

$2.25

Now: $5.48▼

$7.73

Volume75,326 shs

Average Volume82,637 shs

Market Capitalization$205.72 million

P/E RatioN/A

Dividend YieldN/A

Beta1.53

Axcella Health Inc., a clinical-stage biotechnology company, researches and develops endogenous metabolic modulators (EMMs) for the treatment of complex diseases and improving health in the United States. It offers AXA1665 for use in treating overt hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic steatohepatitis; AXA2678 for use in treating muscle atrophy; and AXA4010 to target multiple biological pathways to support normal structures and functions of the blood. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Overall MarketRank^™

1.58 out of 5 stars

Medical Sector

324th out of 1,926 stocks

Biological Products, Except Diagnostic Industry

42nd out of 177 stocks

3.4 Analyst's Opinion

Consensus Rating
Axcella Health has received a consensus rating of Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $17.13, Axcella Health has a forecasted upside of 212.5% from its current price of $5.48.
Amount of Analyst Coverage
Axcella Health has only been the subject of 2 research reports in the past 90 days.

2.8 Community Rank

Outperform Votes
Axcella Health has received 60 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Axcella Health has received 48 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Axcella Health has received 55.56% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Axcella Health and other stocks. Vote “Outperform” if you believe AXLA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AXLA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Axcella Health does not currently pay a dividend.
Dividend Growth
Axcella Health does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Axcella Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 10.40% of the stock of Axcella Health is held by insiders.
Percentage Held by Institutions
66.77% of the stock of Axcella Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Axcella Health are expected to decrease in the coming year, from ($1.76) to ($1.89) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Axcella Health is -2.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Axcella Health is -2.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Axcella Health has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Biological products, except diagnostic

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:AXLA

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.axcellahealth.com

Phone857-320-2200

Employees66

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.28

Current Ratio22.66

Quick Ratio22.66

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$2.61 per share

Price / Book2.10

Profitability

EPS (Most Recent Fiscal Year)($3.55)

Net Income$-59,040,000.00

Net MarginsN/A

Return on Equity-79.03%

Return on Assets-54.77%

Miscellaneous

Outstanding Shares37,541,000

Market Cap$205.72 million

Next Earnings Date3/22/2021 (Estimated)

OptionableNot Optionable

$5.48

-0.30 (-5.19 %)

(As of 01/27/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.

Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

How has Axcella Health's stock price been impacted by Coronavirus?

Axcella Health's stock was trading at $3.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXLA stock has increased by 65.1% and is now trading at $5.48.
View which stocks have been most impacted by COVID-19.

Is Axcella Health a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Axcella Health stock.
View analyst ratings for Axcella Health or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Axcella Health?

Wall Street analysts have given Axcella Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Axcella Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Bill Hinshaw's approval rating as Axcella Health's CEO?

3 employees have rated Axcella Health CEO Bill Hinshaw on Glassdoor.com. Bill Hinshaw has an approval rating of 100% among Axcella Health's employees. This puts Bill Hinshaw in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Monday, March 22nd 2021.
View our earnings forecast for Axcella Health.

How were Axcella Health's earnings last quarter?

Axcella Health Inc. (NASDAQ:AXLA) announced its earnings results on Tuesday, November, 17th. The company reported ($0.34) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.41) by $0.07.
View Axcella Health's earnings history.

What price target have analysts set for AXLA?

9 brokers have issued 1 year target prices for Axcella Health's stock. Their forecasts range from $9.00 to $28.00. On average, they anticipate Axcella Health's share price to reach $17.13 in the next year. This suggests a possible upside of 212.5% from the stock's current price.
View analysts' price targets for Axcella Health or view Wall Street analyst' top-rated stocks.

Are investors shorting Axcella Health?

Axcella Health saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 332,000 shares, an increase of 19.3% from the December 15th total of 278,400 shares. Based on an average trading volume of 95,400 shares, the days-to-cover ratio is currently 3.5 days. Currently, 2.1% of the company's shares are sold short.
View Axcella Health's Short Interest.

Who are some of Axcella Health's key competitors?

Some companies that are related to Axcella Health include Prevail Therapeutics (PRVL), Compugen (CGEN), Tarsus Pharmaceuticals (TARS), Agenus (AGEN), Adaptimmune Therapeutics (ADAP), Osiris Therapeutics (OSIR), Gritstone Oncology (GRTS), Athira Pharma (ATHA), Precision BioSciences (DTIL), SQZ Biotechnologies (SQZ), DBV Technologies (DBVT), MeiraGTx (MGTX), Orchard Therapeutics (ORTX), Curis (CRIS) and Poseida Therapeutics (PSTX).
View all of AXLA's competitors.

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Evofem Biosciences (EVFM), ADMA Biologics (ADMA), Coty (COTY), Energy Transfer (ET), Myovant Sciences (MYOV), NVIDIA (NVDA), Pfizer (PFE) and Moderna (MRNA).

Who are Axcella Health's key executives?

Axcella Health's management team includes the following people:

Mr. William R. Hinshaw Jr., Pres, CEO & Director (Age 52, Pay $785.48k)
Dr. Manu V. Chakravarthy M.D., Ph.D., Exec. VP of Clinical Devel. & Chief Medical Officer (Age 47, Pay $529.21k)
Mr. Laurent Chardonnet, Sr. VP & CFO (Age 56)
Dr. Paul Fehlner J.D., Ph.D., Sr. VP, Chief Legal Officer & Corp. Sec. (Age 57)
Mr. Andrew J. Suchoff, Sr. VP & Chief People Officer
Dr. Larry Bell, Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP

When did Axcella Health IPO?

(AXLA) raised $76 million in an IPO on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $5.48.

How big of a company is Axcella Health?

Axcella Health has a market capitalization of $205.72 million. The company earns $-59,040,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis. Axcella Health employs 66 workers across the globe.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here